Medpace Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All 01P.F news ›SEC Form 10-Q filed by Medpace Holdings Inc.
Plus members following MEDP got this by push and email at 16:02:50 ET - 4.0s after publication. Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the…
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
Plus members following MEDP got this by push and email at 16:15:04 ET - 4.5s after publication. Quantisnow reads SEC filings, FDA decisions, analyst ratings, insider trades and press releases straight off the wire and alerts you on the…
More from 1 other outlet
Insider Selling: Medpace (NASDAQ:MEDP) VP Sells $2,667,380.00 in Stock
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) VP Susan Burwig sold 3,940 shares of the business’s stock in a transaction on Tuesday, October 27th. The shares were sold at an average price of $677.00, for a total value of…
Medpace: Downgrade 'Hold' Revenue Growth Guidance Change And Slightly Lower Backlog Conversion Rate
Medpace Holdings is downgraded from "Buy" to "Hold" due to decelerating growth metrics and underwhelming forward guidance. Q3 2026 Net New Business Awards rose just 10.6%, a sharp slowdown from Q2's ... - Medpace Holdings is downgraded…
Medpace forecasts 2026 EPS of $17.97-$18.32 as $1B buyback authorization replaces prior program
Medpace Q3 2026 earnings: record awards, raised 2026 guidance, and 2027 outlook tied to cancellations and Q4 bookings. Earnings Call Insights: Medpace (MEDP) Q3 2026 - “The business environment remains strong in quarter 3 2026,” and…
Medpace Slips Despite Third-Quarter Beat, Solid Earnings Outlook
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Medpace Holdings, Inc. (MEDP) Q3 2026 Earnings Call Transcript
Medpace Holdings, Inc. (MEDP) Q3 2026 Earnings Call October 22, 2026 9:00 AM EDT David Ruhe - Associate Director of Financial Planning & AnalysisAugust Troendle - CEO, President & ChairmanKevin Brady - CFO & Treasurer Good day, ladies and…
Medpace Holdings Jumps 5.1% Amid Sector-Wide Rally
Medpace Holdings, Inc. surged 5.1% on Wednesday, October 21, 2026, riding a powerful rally across the diagnostics and research sector. The stock closed at $... The post Medpace Holdings Jumps 5.1% Amid Sector-Wide Rally first appeared on…
Medpace (NASDAQ:MEDP) reports Q3 2026 in line with expectations
Clinical research company Medpace Holdings (NASDAQ:MEDP) met Wall Street’s revenue expectations in Q3 2026, with sales up 8.5% year on year to $716 million. The company’s outlook for the full year was close to analysts’ estimates with…
Tranche Update on Medpace Holdings, Inc.'s Equity Buyback Plan announced on October 24, 2022.
From July 1, 2026 to September 30, 2026, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,204,015 shares, representing... Published on 10/21/2026 at 04:15 pm EDT…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- seekingalpha.com6
- quantisnow.com4
- stocktitan.net4
- themarketsdaily.com3
- marketscreener.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.